ASR Vermogensbeheer N.V. Buys New Position in The Cooper Companies, Inc. (NASDAQ:COO)

ASR Vermogensbeheer N.V. acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 3,599 shares of the medical device company's stock, valued at approximately $304,000.

Other large investors have also bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its stake in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after purchasing an additional 2,957,421 shares in the last quarter. FMR LLC boosted its stake in shares of Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock valued at $203,911,000 after purchasing an additional 1,095,805 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Cooper Companies by 17.0% during the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock valued at $399,340,000 after purchasing an additional 686,751 shares in the last quarter. SG Americas Securities LLC raised its position in shares of Cooper Companies by 8,337.0% during the first quarter. SG Americas Securities LLC now owns 369,542 shares of the medical device company's stock worth $31,171,000 after acquiring an additional 365,162 shares during the last quarter. Finally, Alecta Tjanstepension Omsesidigt raised its position in shares of Cooper Companies by 55.8% during the first quarter. Alecta Tjanstepension Omsesidigt now owns 839,700 shares of the medical device company's stock worth $70,829,000 after acquiring an additional 300,700 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Loop Capital set a $100.00 price objective on Cooper Companies in a research report on Tuesday, June 17th. UBS Group upgraded Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Wall Street Zen downgraded Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. BNP Paribas upgraded Cooper Companies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 22nd. Finally, BNP Paribas Exane upgraded Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a research report on Tuesday, July 22nd. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $96.73.

Cooper Companies Stock Down 1.1%

Cooper Companies stock traded down $0.82 during mid-day trading on Thursday, reaching $73.46. The stock had a trading volume of 805,949 shares, compared to its average volume of 2,160,441. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38. The stock's 50-day simple moving average is $71.86 and its 200-day simple moving average is $79.46. The firm has a market capitalization of $14.69 billion, a PE ratio of 35.66, a price-to-earnings-growth ratio of 1.77 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. During the same quarter last year, the firm posted $0.85 earnings per share. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.